Published: 06/3/2026 | Author: Nikki Wisher

Philadelphia is on the verge of a milestone in its fight against the opioid overdose crisis, but health officials warn that a rising stimulant threat and persistent gaps in the recovery pipeline demand continued urgency.

In 2024, there were 1,069 overdose fatalities in Philadelphia, an 18% decrease from 2023 and a 24% drop from the all-time peak of 1,413 deaths recorded in 2022.

Preliminary state data suggest deaths may fall further still, to 921 in 2025, which would mark the first time Philadelphia has recorded fewer than 1,000 overdose fatalities in nearly ten years.

For Pennsylvanians seeking opioid treatment or NA meetings in Philadelphia, the data offers real encouragement, alongside a clear-eyed warning about what’s next.

The Opioid Crisis by the Numbers in Philadelphia

Since 2020, 6,281 people have fatally overdosed in Philadelphia. The back-to-back annual declines represent a meaningful reversal after years of record-setting death tolls, but officials stress the work is nowhere near finished.

Experts credit a combination of factors for the decline: broader community outreach, improved access to opioid treatment and shifts in the local drug supply.

As the city’s director of Substance Use Prevention and Harm Reduction, Daniel Teixeira da Silva, put it: “Overdoses are not going down for everyone.” Certain neighborhoods and populations continue to see higher concentrations of opioid-related deaths, underscoring that citywide progress does not mean uniform progress.

What Is Driving the Decline in Opioid Overdose Deaths

A standout factor in Philadelphia’s turnaround has been aggressive, boots-on-the-ground naloxone distribution. City officials credited a 2024 program through the Overdose Response Unit that delivered naloxone, the opioid-overdose-reversing medication sold under the brand name Narcan.

Medication was delivered to neighborhoods with high concentrations of overdose deaths. This included parts of North Philadelphia where fatalities had been climbing for years.

Workers knocked on hundreds of thousands of doors offering the medication to residents in communities that had historically received fewer harm reduction resources.

Expanded access to medication-assisted treatment for opioid addiction, combined with peer outreach and NA meeting networks, has also contributed to connecting more people with sustained recovery support.

Fentanyl Still Dominates but Stimulants Are Rising

Fentanyl remains the engine of Philadelphia’s overdose crisis. In 2024, 77% of all overdose deaths involved opioids, with illicit fentanyl at the center of most cases.

But a dangerous new pattern is emerging alongside the opioid epidemic: stimulant-involved deaths are climbing even as opioid fatalities fall.

In 2024, opioids and stimulants were co-detected in 50% of all overdose deaths. Deaths involving stimulants but no opioids increased 8.6% from 2023 to 2024.

Adulterants are compounding the danger further. Xylazine, a veterinary sedative increasingly mixed into street opioids, was detected in 34% of all overdose deaths in 2024. A newer veterinary sedative, medetomidine, was found in 9% of overdose deaths after the Medical Examiner’s Office began testing for it in May 2024.

These additives are particularly deadly because naloxone does not reverse their sedative effects, meaning a person can be revived from opioid overdose and still die from xylazine- or medetomidine-induced respiratory failure without further intervention.

Understanding Opioid Addiction and Overdose Risk

Opioids, including fentanyl, heroin, and prescription painkillers, suppress the central nervous system and can stop breathing entirely during an overdose.

Fentanyl is 50 to 100 times more potent than morphine, making accidental overdose especially likely when it contaminates other substances. Naloxone (Narcan) rapidly reverses opioid overdose and is available without a prescription at most Pennsylvania pharmacies.

Harm Reduction and Treatment for Opioid Addiction

Philadelphia’s progress proves that harm reduction and opioid treatment save lives at scale. For anyone struggling with opioid abuse or narcotic addiction, effective options include:

Naloxone/Narcan — Free at many Philadelphia-area pharmacies, health clinics, and city harm reduction sites. Every household should have it.

Medication-Assisted Treatment (MAT) — Buprenorphine (Suboxone) and methadone are FDA-approved treatments for opioid addiction that significantly reduce overdose risk and support long-term recovery.

Fentanyl Test Strips — Legal in Pennsylvania and available through harm reduction programs, these allow people to screen substances for fentanyl contamination.

Narcotics Anonymous — NA meetings offer free, peer-based recovery support for anyone dealing with narcotic addiction, with no requirement to be in formal treatment.

You can search narcotics.com’s directory to find NA meetings in your area. Call 800-934-1582(Sponsored) to speak with a treatment specialist today.